Allergy and Infectious Diseases Research in Tennessee
Allergy and Infectious Diseases Research (93.855) awarded $495 million to recipients in Tennessee in 300 grants from fiscal 2021 to 2025, 2.3% of the program's national total. Vanderbilt University Medical Center received the most, $281 million.
- Awarded in Tennessee$495 million
- Awards300
- Share of the program2.3%
- Rank among states12th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 155 | $102 million |
| FY 2022 | 150 | $103 million |
| FY 2023 | 155 | $89.8 million |
| FY 2024 | 149 | $115 million |
| FY 2025 | 140 | $84.4 million |
Recipients in Tennessee
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Vanderbilt University Medical Center | Nonprofits | 130 | $281 million |
| St Jude Children's Research Hospital Inc | Colleges and universities | 57 | $110 million |
| University of Tennessee | Colleges and universities | 28 | $52.4 million |
| Vanderbilt University | Colleges and universities | 44 | $24.5 million |
| Meharry Medical College | Colleges and universities | 10 | $7.9 million |
| University of Tennessee | Colleges and universities | 7 | $6.9 million |
| East Tennessee State University | Colleges and universities | 10 | $5.8 million |
| Immuno Technologies Inc | Small businesses | 2 | $3.3 million |
| Decode Health, Inc. | Small businesses | 2 | $1.2 million |
| Iquity Labs Inc | Small businesses | 1 | $499,918 |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Tennessee?
$495 million from fiscal 2021 to 2025, across 300 awards. Tennessee ranks 12th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Tennessee?
The largest recipient is Vanderbilt University Medical Center, with $281 million in 130 awards. Next are St Jude Children's Research Hospital Inc and University of Tennessee.
Can organizations in Tennessee apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Tennessee
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start